Cargando…
Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development
Rationale: Impaired cognitive abilities are a key characteristic of schizophrenia. Although currently approved pharmacological treatments have demonstrated efficacy for positive symptoms, to date no pharmacological treatments successfully reverse cognitive dysfunction in these patients. Cognitively-...
Autores principales: | Acheson, Dean T., Twamley, Elizabeth W., Young, Jared W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684768/ https://www.ncbi.nlm.nih.gov/pubmed/23785309 http://dx.doi.org/10.3389/fnins.2013.00103 |
Ejemplares similares
-
Pharmacological Augmentation of Psychosocial and Remediation Training Efforts in Schizophrenia
por: Harvey, Philip D., et al.
Publicado: (2017) -
Enhancing Neuroplasticity to Augment Cognitive Remediation in Schizophrenia
por: Jahshan, Carol, et al.
Publicado: (2017) -
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review
por: Barlati, Stefano, et al.
Publicado: (2019) -
Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology
por: Geerts, Hugo, et al.
Publicado: (2015) -
Cognitive Remediation in Schizophrenia
por: Kaneko, Yoshio, et al.
Publicado: (2012)